Amgen Inc
AMGN
NASDAQ
Biotechnology
$415.21
USD
-2.63 (-0.63%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $225.90B
Volume 1.7M
Price Target
$303.00 – $450.00
USD
The 5 analysts offering 1-year price forecasts have a max estimate of $450.00 and a min estimate of $303.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$357.20
-$3.9 vs prior
Implied Upside
-14.0%
-0.9% vs prior
Analyst Covering
5
-5 vs prior period
Consensus
Hold
Unchanged vs prior
Signal Quality
Consensus Freshness
33%
Many ratings are older - consensus may be less current
Analyst Agreement
Moderate
Targets show moderate spread across analysts
Mean vs Median
$14 Gap
Median $343.00 vs avg $357.20 - a few bullish outliers are pulling the average up
Analyst Consensus
Strong Sell
Hold
Strong Buy
Hold
1 Buy
4 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
1
Hold
4
Sell
0
Strong Sell
0
5 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Evan David Seigerman | BMO Capital | Buy | Maintained | 1 week ago | Plus | Plus | Plus |
Vamil Divan | Guggenheim | Hold | Maintained | 4 weeks ago | Plus | Plus | Plus |
Carter Gould | Cantor Fitzgerald | Hold | Reiterated | 1 month ago | Plus | Plus | Plus |
Salim Syed | Mizuho | Hold | Maintained | 2 months ago | Plus | Plus | Plus |
Terence Flynn | Morgan Stanley | Hold | Maintained | 2 months ago | Plus | Plus | Plus |
Frequently Asked Questions
